MK-677 and enclomiphene stack: what the science actually shows

What's this video probably claiming?

Based on the caption referencing a "4 month cycle" with before-and-after framing, @frescobrando is almost certainly showing body composition changes and attributing them to a combination of MK-677 (ibutamoren) and enclomiphene. The implicit claims here are predictable: MK-677 boosted growth hormone and IGF-1 leading to muscle gain or fat loss, while enclomiphene raised endogenous testosterone levels, and together they produced visible physique improvements. The creator is likely positioning this stack as a cleaner, more accessible alternative to traditional anabolic steroids or exogenous growth hormone. Before-and-after content in this category almost universally credits the compounds for everything while giving zero weight to training, diet, sleep, or lighting changes between photos. That framing is doing a lot of heavy lifting, and it deserves serious scrutiny.

What does the science actually show?

MK-677 does produce measurable GH and IGF-1 increases. Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism) demonstrated sustained IGF-1 elevation over 12 months in older adults at 25mg daily, but lean mass gains were modest and not accompanied by meaningful strength improvements. Importantly, that study also flagged increased fasting glucose and insulin resistance as consistent side effects. On enclomiphene, the data is more encouraging for its intended use: Wiehle et al. (2014, Andrology) showed that enclomiphene 12.5-25mg restored serum testosterone to normal range in hypogonadal men while preserving spermatogenesis, unlike exogenous testosterone. However, neither compound has been studied in combination, and neither has been trialed specifically in healthy, eugonadal men seeking physique enhancement, which is almost certainly the population watching this video.

Where does the social media noise diverge from clinical reality?

The gap between TikTok claims and clinical data here is significant. MK-677 is frequently called a "peptide" online, but it is actually a non-peptide ghrelin receptor agonist and a selective agonist for the growth hormone secretagogue receptor. It is not FDA-approved for any indication. Enclomiphene has an FDA-approved formulation history, but it is prescribed for male hypogonadism with documented hormonal deficiency, not for performance enhancement in men with normal testosterone levels. Stacking these two compounds assumes additive benefits with no interaction data to support that assumption. The before-and-after format is especially problematic: four months of consistent gym training alone produces visible results in most people, and isolating the compound effect from confounders is impossible in a single individual's anecdotal experience. Water retention from elevated GH activity can also produce a "fuller" look that reads as muscle gain but reverses on discontinuation.

What should you actually know?

If you are considering either of these compounds, there are practical things worth understanding that this video almost certainly skips. MK-677 reliably increases appetite and can cause significant water retention and temporary insulin resistance, documented consistently across trials including Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism). Enclomiphene's safety profile in long-term use outside of hypogonadism treatment is not well established, and using it without confirmed low testosterone and without monitoring estrogen levels creates real risk of estrogenic side effects, given its mixed agonist-antagonist profile at estrogen receptors. Neither compound is approved by the FDA for the purposes shown in this video. Both require a legitimate clinical evaluation before consideration. A four-month TikTok transformation does not constitute evidence that this stack works as shown, or that it is safe for the person watching at home.